ADIPOQ and type 2 diabetes mellitus: A 2017 study reported lower serum adiponectin levels in patients with type 2 diabetes mellitus (T2DM) and stage 1 CKD than in patients with T2DM without renal pathology, with progressively higher levels coinciding with the deterioration of kidney function26.